Simvastatin

chemokine (C-C motif) ligand 2 ; Mus musculus







11 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35618653 A ROS-Responsive Simvastatin Nano-Prodrug and its Fibronectin-Targeted Co-Delivery System for Atherosclerosis Treatment. 2022 Jun 8 1
2 30312114 Repurposing simvastatin as a therapy for preterm labor: evidence from preclinical models. 2019 Feb 1
3 28758631 Statins are ineffective at reducing neuroinflammation or prolonging survival in scrapie-infected mice. 2017 Aug 1
4 27021071 Statin modulation of monocyte phenotype and function: implications for HIV-1-associated neurocognitive disorders. 2016 Oct 3
5 23564080 Simvastatin suppresses vascular inflammation and atherosclerosis in ApoE(-/-) mice by downregulating the HMGB1-RAGE axis. 2013 Jun 1
6 22267540 Statins inhibit monocyte chemotactic protein 1 expression in endometriosis. 2012 Jun 2
7 22583375 Differential effects of simvastatin on IL-13-induced cytokine gene expression in primary mouse tracheal epithelial cells. 2012 May 14 1
8 22683568 Critical role for integrin-β4 in the attenuation of murine acute lung injury by simvastatin. 2012 Aug 15 1
9 16321392 Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages. 2006 Sep 1
10 15781755 HMG-CoA reductase inhibition reduces monocyte CC chemokine receptor 2 expression and monocyte chemoattractant protein-1-mediated monocyte recruitment in vivo. 2005 Mar 22 1
11 12818400 Simvastatin inhibits expression of tissue factor in advanced atherosclerotic lesions of apolipoprotein E deficient mice independently of lipid lowering: potential role of simvastatin-mediated inhibition of Egr-1 expression and activation. 2003 Apr 1